{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:17:52Z","timestamp":1790619472760,"version":"4.1.0"},"reference-count":163,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)","award":["398066876\/GRK 2485\/2"],"award-info":[{"award-number":["398066876\/GRK 2485\/2"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Rift Valley Fever Virus is a mosquito-borne phlebovirus causing febrile or haemorrhagic illness in ruminants and humans. The virus can prevent the induction of the antiviral interferon response through its NSs proteins. Mutations in the NSs gene may allow the induction of innate proinflammatory immune responses and lead to attenuation of the virus. Upon infection, virus-specific antibodies and T cells are induced that may afford protection against subsequent infections. Thus, all arms of the adaptive immune system contribute to prevention of disease progression. These findings will aid the design of vaccines using the currently available platforms. Vaccine candidates have shown promise in safety and efficacy trials in susceptible animal species and these may contribute to the control of RVFV infections and prevention of disease progression in humans and ruminants.<\/jats:p>","DOI":"10.3390\/pathogens12091174","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T23:11:52Z","timestamp":1695165112000},"page":"1174","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Rift Valley Fever Virus\u2014Infection, Pathogenesis and Host Immune Responses"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3374-3321","authenticated-orcid":false,"given":"Niranjana","family":"Nair","sequence":"first","affiliation":[{"name":"Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Foundation, 30559 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6535-3497","authenticated-orcid":false,"given":"Albert D. M. E.","family":"Osterhaus","sequence":"additional","affiliation":[{"name":"Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Foundation, 30559 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1921-4581","authenticated-orcid":false,"given":"Guus F.","family":"Rimmelzwaan","sequence":"additional","affiliation":[{"name":"Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Foundation, 30559 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6631-2096","authenticated-orcid":false,"given":"Chittappen Kandiyil","family":"Prajeeth","sequence":"additional","affiliation":[{"name":"Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Foundation, 30559 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Koch, J., Xin, Q., Tischler, N.D., and Lozach, P.-Y. (2021). Entry of Phenuiviruses into Mammalian Host Cells. Viruses, 13.","DOI":"10.3390\/v13020299"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1002\/jmv.27618","article-title":"Highly adaptive Phenuiviridae with biomedical importance in multiple fields","volume":"94","author":"Sun","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2478\/jvetres-2021-0009","article-title":"Rift Valley fever\u2014A growing threat to humans and animals","volume":"65","author":"Rola","year":"2021","journal-title":"J. Vet. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.virusres.2019.03.010","article-title":"The role of co-infection and swarm dynamics in arbovirus transmission","volume":"265","author":"Ciota","year":"2019","journal-title":"Virus Res."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Kormelink, R., Verchot, J., Tao, X., and Desbiez, C. (2021). The Bunyavirales: The Plant-Infecting Counterparts. Viruses, 13.","DOI":"10.3390\/v13050842"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e00239-18","DOI":"10.1128\/mSphere.00239-18","article-title":"The Unique Phylogenetic Position of a Novel Tick-Borne Phlebovirus Ensures an Ixodid Origin of the Genus Phlebovirus","volume":"3","author":"Matsuno","year":"2018","journal-title":"mSphere"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/path.1700340418","article-title":"Enzootic Hepatitis or Rift Valley Fever. An Undescribed Virus Disease of Sheep Cattle and Man from East Africa","volume":"34","author":"Daubney","year":"1931","journal-title":"J. Pathol. Bacteriol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1084\/jem.59.3.305","article-title":"Rift Valley Fever in Man: Report of a Fatal Laboratory Infection Complicated by Thrombophlebitis","volume":"59","author":"Schwentker","year":"1934","journal-title":"J. Exp. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/tbed.13402","article-title":"Seroprevalence of Rift valley fever in South African domestic and wild suids (1999\u20132016)","volume":"67","author":"Lubisi","year":"2020","journal-title":"Transbound. Emerg. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fvets.2015.00063","article-title":"Serological Evidence of Rift Valley Fever Virus Circulation in Domestic Cattle and African Buffalo in Northern Botswana (2010\u20132011)","volume":"2","author":"Jori","year":"2015","journal-title":"Front. Vet. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Britch, S.C., Binepal, Y.S., Ruder, M.G., Kariithi, H.M., Linthicum, K.J., Anyamba, A., Small, J.L., Tucker, C.J., Ateya, L.O., and Oriko, A.A. (2013). Rift Valley Fever Risk Map Model and Seroprevalence in Selected Wild Ungulates and Camels from Kenya. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0066626"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"6559193","DOI":"10.1155\/2022\/6559193","article-title":"Serological Evidence of Antibodies to Rift Valley Fever Virus in Wild and Domestic Animals in Bauchi State, Nigeria","volume":"2022","author":"Atuman","year":"2022","journal-title":"Vet. Med. Int."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Gakuya, F., Akoko, J., Wambua, L., Nyamota, R., Ronoh, B., Lekolool, I., Mwatondo, A., Muturi, M., Ouma, C., and Nthiwa, D. (2022). Evidence of co-exposure with Brucella spp, Coxiella burnetii, and Rift Valley fever virus among various species of wildlife in Kenya. PLoS Negl. Trop. Dis., 16.","DOI":"10.1371\/journal.pntd.0010596"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.3201\/eid1710.110397","article-title":"Unexpected Rift Valley Fever Outbreak, Northern Mauritania","volume":"17","author":"Baba","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/tbed.12142","article-title":"Molecular and Serological Studies on the Rift Valley Fever Outbreak in Mauritania in 2010","volume":"60","author":"Eiden","year":"2013","journal-title":"Transbound. Emerg. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Fang, Y., Khater, E.I.M., Xue, J.-B., Ghallab, E.H.S., Li, Y.-Y., Jiang, T.-G., and Li, S.-Z. (2022). Epidemiology of Mosquito-Borne Viruses in Egypt: A Systematic Review. Viruses, 14.","DOI":"10.3390\/v14071577"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Grossi-Soyster, E.N., Lee, J., King, C.H., and LaBeaud, A.D. (2019). The influence of raw milk exposures on Rift Valley fever virus transmission. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0007258"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Msimang, V., Thompson, P.N., van Vuren, P.J., Tempia, S., Cordel, C., Kgaladi, J., Khosa, J., Burt, F.J., Liang, J., and Rostal, M.K. (2019). Rift Valley Fever Virus Exposure amongst Farmers, Farm Workers, and Veterinary Professionals in Central South Africa. Viruses, 11.","DOI":"10.3390\/v11020140"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Oymans, J., Wichgers Schreur, P.J., Van Keulen, L., Kant, J., and Kortekaas, J. (2020). Rift Valley fever virus targets the maternal-foetal interface in ovine and human placentas. PLoS Negl. Trop. Dis., 14.","DOI":"10.1371\/journal.pntd.0007898"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1099\/jgv.0.001296","article-title":"Rift Valley fever: Biology and epidemiology","volume":"100","author":"Wright","year":"2019","journal-title":"J. Gen. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Gerken, K.N., LaBeaud, A.D., Mandi, H., Jackson, M.L., Breugelmans, J.G., and King, C.H. (2022). Paving the way for human vaccination against Rift Valley fever virus: A systematic literature review of RVFV epidemiology from 1999 to 2021. PLoS Negl. Trop. Dis., 16.","DOI":"10.1371\/journal.pntd.0009852"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e864","DOI":"10.1016\/S2214-109X(16)30176-0","article-title":"Association of Rift Valley fever virus infection with miscarriage in Sudanese women: A cross-sectional study","volume":"4","author":"Baudin","year":"2016","journal-title":"Lancet Glob. Health"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5520","DOI":"10.1016\/j.vaccine.2015.08.020","article-title":"Rift Valley fever virus: A review of diagnosis and vaccination, and implications for emergence in Europe","volume":"33","author":"Mansfield","year":"2015","journal-title":"Vaccine"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4103\/0972-9062.302042","article-title":"Serological evidence of Rift Valley fever virus among humans in Mersin province of Turkey","volume":"56","author":"Kurnaz","year":"2019","journal-title":"J. Vector Borne Dis."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Grossi-Soyster, E.N., and LaBeaud, A.D. (2020). Rift Valley Fever: Important Considerations for Risk Mitigation and Future Outbreaks. Trop. Med. Infect. Dis., 5.","DOI":"10.3390\/tropicalmed5020089"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"10341","DOI":"10.1128\/JVI.01191-08","article-title":"Three-Dimensional Organization of Rift Valley Fever Virus Revealed by Cryoelectron Tomography","volume":"82","author":"Freiberg","year":"2008","journal-title":"J. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"11769","DOI":"10.1073\/pnas.1001760107","article-title":"Structure of the Rift Valley fever virus nucleocapsid protein reveals another architecture for RNA encapsidation","volume":"107","author":"Raymond","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Ferron, F., Li, Z., Danek, E.I., Luo, D., Wong, Y., Coutard, B., Lantez, V., Charrel, R., Canard, B., and Walz, T. (2011). The Hexamer Structure of the Rift Valley Fever Virus Nucleoprotein Suggests a Mechanism for its Assembly into Ribonucleoprotein Complexes. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1002030"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Mottram, T.J., Li, P., Dietrich, I., Shi, X., Brennan, B., Varjak, M., and Kohl, A. (2017). Mutational analysis of Rift Valley fever phlebovirus nucleocapsid protein indicates novel conserved, functional amino acids. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0006155"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e0171321","DOI":"10.1128\/jvi.01713-21","article-title":"Structure of Rift Valley Fever Virus RNA-Dependent RNA Polymerase","volume":"96","author":"Wang","year":"2022","journal-title":"J. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Alamri, M.A., Mirza, M.U., Adeel, M.M., Ashfaq, U.A., Qamar, M.T.U., Shahid, F., Ahmad, S., Alatawi, E.A., Albalawi, G.M., and Allemailem, K.S. (2022). Structural Elucidation of Rift Valley Fever Virus L Protein towards the Discovery of Its Potential Inhibitors. Pharmaceuticals, 15.","DOI":"10.3390\/ph15060659"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Borrego, B., Moreno, S., L\u00f3pez-Vali\u00f1as, \u00c1., de la Losa, N., Weber, F., N\u00fa\u00f1ez, J.I., and Brun, A. (2022). Identification of Single Amino Acid Changes in the Rift Valley Fever Virus Polymerase Core Domain Contributing to Virus Attenuation In Vivo. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.875539"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1038\/emi.2014.71","article-title":"The Rift Valley fever accessory proteins NSm and P78\/NSm-GN are distinct determinants of virus propagation in vertebrate and invertebrate hosts","volume":"3","author":"Kreher","year":"2014","journal-title":"Emerg. Microbes Infect."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"E7564","DOI":"10.1073\/pnas.1705176114","article-title":"Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope","volume":"114","author":"Wu","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1073\/pnas.1217780110","article-title":"Crystal structure of glycoprotein C from Rift Valley fever virus","volume":"110","author":"Dessau","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41467-017-02789-2","article-title":"Shielding and activation of a viral membrane fusion protein","volume":"9","author":"Halldorsson","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1038\/s41467-020-17101-y","article-title":"NSs amyloid formation is associated with the virulence of Rift Valley fever virus in mice","volume":"11","author":"Nachman","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/JVI.01768-20","article-title":"The NSs Protein Encoded by the Virulent Strain of Rift Valley Fever Virus Targets the Expression of Abl2 and the Actin Cytoskeleton of the Host, Affecting Cell Mobility, Cell Shape, and Cell-Cell Adhesion","volume":"95","author":"Bamia","year":"2020","journal-title":"J. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"13335","DOI":"10.1128\/JVI.01238-07","article-title":"NSm Protein of Rift Valley Fever Virus Suppresses Virus-Induced Apoptosis","volume":"81","author":"Won","year":"2007","journal-title":"J. Virol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Kading, R.C., Crabtree, M.B., Bird, B.H., Nichol, S.T., Erickson, B.R., Horiuchi, K., Biggerstaff, B.J., and Miller, B.R. (2014). Deletion of the NSm Virulence Gene of Rift Valley Fever Virus Inhibits Virus Replication in and Dissemination from the Midgut of Aedes aegypti Mosquitoes. PLoS Negl. Trop. Dis., 8.","DOI":"10.1371\/journal.pntd.0002670"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"13767","DOI":"10.1128\/JVI.01364-12","article-title":"Heparan Sulfate Facilitates Rift Valley Fever Virus Entry into the Cell","volume":"86","author":"Kortekaas","year":"2012","journal-title":"J. Virol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1128\/JVI.02628-12","article-title":"Severe Fever with Thrombocytopenia Virus Glycoproteins Are Targeted by Neutralizing Antibodies and Can Use DC-SIGN as a Receptor for pH-Dependent Entry into Human and Animal Cell Lines","volume":"87","author":"Hofmann","year":"2013","journal-title":"J. Virol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/tra.12393","article-title":"Differential Use of the C-Type Lectins L-SIGN and DC-SIGN for Phlebovirus Endocytosis","volume":"17","author":"Tetard","year":"2016","journal-title":"Traffic"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.chom.2011.06.007","article-title":"DC-SIGN as a Receptor for Phleboviruses","volume":"10","author":"Lozach","year":"2011","journal-title":"Cell Host Microbe"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1128\/JVI.02141-13","article-title":"Nonmuscle Myosin Heavy Chain IIA Is a Critical Factor Contributing to the Efficiency of Early Infection of Severe Fever with Thrombocytopenia Syndrome Virus","volume":"88","author":"Sun","year":"2014","journal-title":"J. Virol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1016\/j.cell.2021.09.001","article-title":"Lrp1 is a host entry factor for Rift Valley fever virus","volume":"184","author":"Ganaie","year":"2021","journal-title":"Cell"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"12954","DOI":"10.1128\/JVI.02242-12","article-title":"Rift Valley Fever Virus Strain MP-12 Enters Mammalian Host Cells via Caveola-Mediated Endocytosis","volume":"86","author":"Harmon","year":"2012","journal-title":"J. Virol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Filone, C.M., Hanna, S.L., Caino, M.C., Bambina, S., Doms, R.W., and Cherry, S. (2010). Rift Valley Fever Virus Infection of Human Cells and Insect Hosts Is Promoted by Protein Kinase C Epsilon. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0015483"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"13642","DOI":"10.1128\/JVI.01973-12","article-title":"Acid-Activated Structural Reorganization of the Rift Valley Fever Virus Gc Fusion Protein","volume":"86","author":"Kortekaas","year":"2012","journal-title":"J. Virol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Willensky, S., Bar-Rogovsky, H., Bignon, E.A., Tischler, N.D., Modis, Y., and Dessau, M. (2016). Crystal Structure of Glycoprotein C from a Hantavirus in the Post-fusion Conformation. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005948"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.1074\/jbc.RA119.007618","article-title":"Cellular cholesterol abundance regulates potassium accumulation within endosomes and is an important determinant in bunyavirus entry","volume":"294","author":"Charlton","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.tim.2019.12.006","article-title":"The Cap-Snatching Mechanism of Bunyaviruses","volume":"28","author":"Olschewski","year":"2020","journal-title":"Trends Microbiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1080\/15548627.2021.1994296","article-title":"Bunyavirus SFTSV exploits autophagic flux for viral assembly and egress","volume":"18","author":"Yan","year":"2022","journal-title":"Autophagy"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/JVI.00968-17","article-title":"Sorafenib Impedes Rift Valley Fever Virus Egress by Inhibiting Valosin-Containing Protein Function in the Cellular Secretory Pathway","volume":"91","author":"Brahms","year":"2017","journal-title":"J. Virol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3390\/v3050493","article-title":"The Pathogenesis of Rift Valley Fever","volume":"3","author":"Ikegami","year":"2011","journal-title":"Viruses"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fvets.2020.00137","article-title":"Increased Susceptibility of Cattle to Intranasal RVFV Infection","volume":"7","author":"Kroeker","year":"2020","journal-title":"Front. Vet. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Odendaal, L., Davis, A.S., and Venter, E.H. (2021). Insights into the Pathogenesis of Viral Haemorrhagic Fever Based on Virus Tropism and Tissue Lesions of Natural Rift Valley Fever. Viruses, 13.","DOI":"10.3390\/v13040709"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/0300985818806049","article-title":"Lesions and Cellular Tropism of Natural Rift Valley Fever Virus Infection in Adult Sheep","volume":"56","author":"Odendaal","year":"2019","journal-title":"Vet. Pathol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/1040638713516759","article-title":"Sensitivity and specificity of real-time reverse transcription polymerase chain reaction, histopathology, and immunohistochemical labeling for the detection of Rift Valley fever virus in naturally infected cattle and sheep","volume":"26","author":"Odendaal","year":"2014","journal-title":"J. Vet. Diagn. Investig."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e0111222","DOI":"10.1128\/jvi.01112-22","article-title":"Rift Valley Fever Virus Infects the Posterior Segment of the Eye and Induces Inflammation in a Rat Model of Ocular Disease","volume":"96","author":"Schwarz","year":"2022","journal-title":"J. Virol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3201\/eid1003.020817","article-title":"Rift Valley Fever Encephalitis","volume":"10","author":"Alrajhi","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Gwon, Y.D., Mahani, S.A.N., Nagaev, I., Mincheva-Nilsson, L., and Evander, M. (2021). Rift Valley Fever Virus Propagates in Human Villous Trophoblast Cell Lines and Induces Cytokine mRNA Responses Known to Provoke Miscarriage. Viruses, 13.","DOI":"10.3390\/v13112265"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jmb.2013.11.024","article-title":"Toll-Like Receptors in Antiviral Innate Immunity","volume":"426","author":"Lester","year":"2014","journal-title":"J. Mol. Biol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3390\/v3060920","article-title":"Pattern Recognition Receptors and the Innate Immune Response to Viral Infection","volume":"3","author":"Thompson","year":"2011","journal-title":"Viruses"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Tolomeo, M., Cavalli, A., and Cascio, A. (2022). STAT1 and Its Crucial Role in the Control of Viral Infections. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23084095"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"8451","DOI":"10.1128\/JVI.03382-12","article-title":"IFITM-2 and IFITM-3 but Not IFITM-1 Restrict Rift Valley Fever Virus","volume":"87","author":"Mudhasani","year":"2013","journal-title":"J. Virol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Confort, M.P., Duboeuf, M., Thiesson, A., Pons, L., Marziali, F., Desloire, S., Ratinier, M., Cimarelli, A., and Arnaud, F. (2023). IFITMs from Naturally Infected Animal Species Exhibit Distinct Restriction Capacities against Toscana and Rift Valley Fever Viruses. Viruses, 15.","DOI":"10.3390\/v15020306"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Habjan, M., Andersson, I., Klingstr\u00f6m, J., Sch\u00fcmann, M., Martin, A., Zimmermann, P., Wagner, V., Pichlmair, A., Schneider, U., and M\u00fchlberger, E. (2008). Processing of Genome 5\u2032 Termini as a Strategy of Negative-Strand RNA Viruses to Avoid RIG-I-Dependent Interferon Induction. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0002032"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Bisom, T.C., White, L.A., Lanchy, J.-M., and Lodmell, J.S. (2022). RIOK3 and Its Alternatively Spliced Isoform Have Disparate Roles in the Innate Immune Response to Rift Valley Fever Virus (MP12) Infection. Viruses, 14.","DOI":"10.3390\/v14092064"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"White, L.A., Bisom, T.C., Grimes, H.L., Hayashi, M., Lanchy, J.-M., and Lodmell, J.S. (2022). Tra2beta-Dependent Regulation of RIO Kinase 3 Splicing During Rift Valley Fever Virus Infection Underscores the Links Between Alternative Splicing and Innate Antiviral Immunity. Front. Cell. Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.799024"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.virol.2013.11.015","article-title":"Rift Valley fever virus infection induces activation of the NLRP3 inflammasome","volume":"449","author":"Ermler","year":"2014","journal-title":"Virology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.virol.2013.11.023","article-title":"Reactive oxygen species activate NF\u03baB (p65) and p53 and induce apoptosis in RVFV infected liver cells","volume":"449","author":"Narayanan","year":"2014","journal-title":"Virology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"7399","DOI":"10.1074\/jbc.M111.296608","article-title":"Induction of DNA Damage Signaling upon Rift Valley Fever Virus Infection Results in Cell Cycle Arrest and Increased Viral Replication","volume":"287","author":"Baer","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Austin, D., Baer, A., Lundberg, L., Shafagati, N., Schoonmaker, A., Narayanan, A., Popova, T., Panthier, J.J., Kashanchi, F., and Bailey, C. (2012). p53 Activation following Rift Valley Fever Virus Infection Contributes to Cell Death and Viral Production. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0036327"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"12766","DOI":"10.1128\/JVI.02333-13","article-title":"Human Parvovirus B19 Infection Causes Cell Cycle Arrest of Human Erythroid Progenitors at Late S Phase That Favors Viral DNA Replication","volume":"87","author":"Luo","year":"2013","journal-title":"J. Virol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1128\/JVI.78.1.104-115.2004","article-title":"Inhibition of S-Phase Cyclin-Dependent Kinase Activity Blocks Expression of Epstein-Barr Virus Immediate-Early and Early Genes, Preventing Viral Lytic Replication","volume":"78","author":"Kudoh","year":"2004","journal-title":"J. Virol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e0018721","DOI":"10.1128\/JVI.00187-21","article-title":"Coronavirus Porcine Epidemic Diarrhea Virus Nucleocapsid Protein Interacts with p53 To Induce Cell Cycle Arrest in S-Phase and Promotes Viral Replication","volume":"95","author":"Su","year":"2021","journal-title":"J. Virol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/JVI.01575-19","article-title":"The Severe Fever with Thrombocytopenia Syndrome Virus NSs Protein Interacts with CDK1 To Induce G2 Cell Cycle Arrest and Positively Regulate Viral Replication","volume":"94","author":"Liu","year":"2020","journal-title":"J. Virol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3389\/fimmu.2019.01182","article-title":"Interferon-\u03b3-Directed Inhibition of a Novel High-Pathogenic Phlebovirus and Viral Antagonism of the Antiviral Signaling by Targeting STAT1","volume":"10","author":"Ning","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"865797","DOI":"10.3389\/fimmu.2022.865797","article-title":"Sandfly Fever Viruses Attenuate the Type I Interferon Response by Targeting the Phosphorylation of JAK-STAT Components","volume":"13","author":"Moalem","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Le May, N., Mansuroglu, Z., L\u00e9ger, P., Josse, T., Blot, G., Billecocq, A., Flick, R., Jacob, Y., Bonnefoy, E., and Bouloy, M. (2008). A SAP30 Complex Inhibits IFN-\u03b2 Expression in Rift Valley Fever Virus Infected Cells. PLoS Pathog., 4.","DOI":"10.1371\/journal.ppat.0040013"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e1000287","DOI":"10.1371\/journal.ppat.1000287","article-title":"Rift Valley Fever Virus NSs Protein Promotes Post-Transcriptional Downregulation of Protein Kinase PKR and Inhibits eIF2\u03b1 Phosphorylation","volume":"5","author":"Ikegami","year":"2009","journal-title":"PLoS Pathog."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.immuni.2013.10.020","article-title":"Antiviral Autophagy Restricts Rift Valley Fever Virus Infection and Is Conserved from Flies to Mammals","volume":"40","author":"Moy","year":"2014","journal-title":"Immunity"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e0181422","DOI":"10.1128\/jvi.01814-22","article-title":"Rift Valley Fever Virus Nucleoprotein Triggers Autophagy to Dampen Antiviral Innate Immune Responses","volume":"97","author":"Zhu","year":"2023","journal-title":"J. Virol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Alem, F., Olanrewaju, A.A., Omole, S., Hobbs, H.E., Ahsan, N., Matulis, G., Brantner, C.A., Zhou, W., Petricoin, E.F., and Liotta, L.A. (2021). Exosomes originating from infection with the cytoplasmic single-stranded RNA virus Rift Valley fever virus (RVFV) protect recipient cells by inducing RIG-I mediated IFN-B response that leads to activation of autophagy. Cell Biosci., 11.","DOI":"10.1186\/s13578-021-00732-z"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Nfon, C.K., Marszal, P., Zhang, S., and Weingartl, H.M. (2012). Innate Immune Response to Rift Valley Fever Virus in Goats. PLoS Negl. Trop. Dis., 6.","DOI":"10.1371\/journal.pntd.0001623"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.virol.2011.09.023","article-title":"Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection","volume":"422","author":"McElroy","year":"2011","journal-title":"Virology"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1099\/vir.0.000119","article-title":"Cytokine response in mouse bone marrow derived macrophages after infection with pathogenic and non-pathogenic Rift Valley fever virus","volume":"96","author":"Roberts","year":"2015","journal-title":"J. Gen. Virol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12985-015-0392-3","article-title":"Serum levels of inflammatory cytokines in Rift Valley fever patients are indicative of severe disease","volume":"12","author":"Shalekoff","year":"2015","journal-title":"Virol. J."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1038\/s41598-017-07543-8","article-title":"Innate Immune Basis for Rift Valley Fever Susceptibility in Mouse Models","volume":"7","author":"Lathan","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"6146","DOI":"10.4049\/jimmunol.1000949","article-title":"A New Mouse Model Reveals a Critical Role for Host Innate Immunity in Resistance to Rift Valley Fever","volume":"185","author":"Valle","year":"2010","journal-title":"J. Immunol."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Cartwright, H.N., Barbeau, D.J., Doyle, J.D., Klein, E., Heise, M.T., Ferris, M.T., and McElroy, A.K. (2022). Genetic diversity of collaborative cross mice enables identification of novel rift valley fever virus encephalitis model. PLoS Pathog., 18.","DOI":"10.1371\/journal.ppat.1010649"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1128\/JVI.02341-13","article-title":"Aerosolized Rift Valley Fever Virus Causes Fatal Encephalitis in African Green Monkeys and Common Marmosets","volume":"88","author":"Hartman","year":"2014","journal-title":"J. Virol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/JVI.01662-17","article-title":"Peripheral Blood Biomarkers of Disease Outcome in a Monkey Model of Rift Valley Fever Encephalitis","volume":"92","author":"Wonderlich","year":"2018","journal-title":"J. Virol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s11250-018-1721-5","article-title":"Seroprevalence of Rift Valley fever virus in cattle in the Democratic Republic of the Congo","volume":"51","author":"Tshilenge","year":"2019","journal-title":"Trop. Anim. Health Prod."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"de Glanville, W.A., Nyarobi, J.M., Kibona, T., Halliday, J.E.B., Thomas, K.M., Allan, K.J., Johnson, P.C.D., Davis, A., Lankester, F., and Claxton, J.R. (2022). Inter-epidemic Rift Valley fever virus infection incidence and risks for zoonotic spillover in northern Tanzania. PLoS Negl. Trop. Dis., 16.","DOI":"10.1371\/journal.pntd.0010871"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4269\/ajtmh.18-0798","article-title":"Circulation of Rift Valley Fever Virus Antibody in Cattle during Inter-Epizootic\/Epidemic Periods in Selected Regions of Tanzania","volume":"101","author":"Salekwa","year":"2019","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"101669","DOI":"10.1016\/j.isci.2020.101669","article-title":"Naturally Acquired Rift Valley Fever Virus Neutralizing Antibodies Predominantly Target the Gn Glycoprotein","volume":"23","author":"Wright","year":"2020","journal-title":"iScience"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1089\/vbz.2009.0205","article-title":"Experimental Infection of Young Adult European Breed Sheep with Rift Valley Fever Virus Field Isolates","volume":"10","author":"Busquets","year":"2010","journal-title":"Vector-Borne Zoonotic Dis."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s11250-014-0540-6","article-title":"Molecular detection of Rift Valley fever virus in serum samples from selected areas of Tanzania","volume":"46","author":"Chengula","year":"2014","journal-title":"Trop. Anim. Health Prod."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4269\/ajtmh.14-0575","article-title":"Elevated Antibodies Against Rift Valley Fever Virus Among Humans with Exposure to Ruminants in Saudi Arabia","volume":"92","author":"Memish","year":"2015","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11250-014-0726-y","article-title":"Seroprevalence of Rift Valley fever virus infection in camels (dromedaries) in northern Tanzania","volume":"47","author":"Swai","year":"2015","journal-title":"Trop. Anim. Health Prod."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1089\/vbz.2016.2065","article-title":"Serological Evidence for the Circulation of Rift Valley Fever Virus in Domestic Small Ruminants in Southern Gabon","volume":"17","author":"Maganga","year":"2017","journal-title":"Vector-Borne Zoonotic Dis."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0042-6822(89)90365-6","article-title":"Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins","volume":"170","author":"Schmaljohn","year":"1989","journal-title":"Virology"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1016\/j.celrep.2018.12.001","article-title":"A Protective Monoclonal Antibody Targets a Site of Vulnerability on the Surface of Rift Valley Fever Virus","volume":"25","author":"Allen","year":"2018","journal-title":"Cell Rep."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41541-018-0052-x","article-title":"A Rift Valley fever virus Gn ectodomain-based DNA vaccine induces a partial protection not improved by APC targeting","volume":"3","author":"Chrun","year":"2018","journal-title":"npj Vaccines"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12985-017-0811-8","article-title":"An equine herpesvirus type 1 (EHV-1) vector expressing Rift Valley fever virus (RVFV) Gn and Gc induces neutralizing antibodies in sheep","volume":"14","author":"Said","year":"2017","journal-title":"Virol. J."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"van Vuren, P.J., Tiemessen, C.T., and Paweska, J.T. (2011). Anti-Nucleocapsid Protein Immune Responses Counteract Pathogenic Effects of Rift Valley Fever Virus Infection in Mice. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0025027"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1128\/JVI.00337-13","article-title":"Rift Valley Fever Virus Clearance and Protection from Neurologic Disease Are Dependent on CD4+ T Cell and Virus-Specific Antibody Responses","volume":"87","author":"Dodd","year":"2013","journal-title":"J. Virol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/JVI.01270-18","article-title":"CD4 T Cells, CD8 T Cells, and Monocytes Coordinate to Prevent Rift Valley Fever Virus Encephalitis","volume":"92","author":"Harmon","year":"2018","journal-title":"J. Virol."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Michaely, L.M., Rissmann, M., Keller, M., K\u00f6nig, R., von Arnim, F., Eiden, M., Rohn, K., Baumg\u00e4rtner, W., Groschup, M., and Ulrich, R. (2022). NSG-Mice Reveal the Importance of a Functional Innate and Adaptive Immune Response to Overcome RVFV Infection. Viruses, 14.","DOI":"10.3390\/v14020350"},{"key":"ref_113","first-page":"107","article-title":"Rift Valley fever; isolation of the virus from wild mosquitoes","volume":"29","author":"Smithburn","year":"1948","journal-title":"Br. J. Exp. Pathol."},{"key":"ref_114","first-page":"1","article-title":"Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine","volume":"30","author":"Smithburn","year":"1949","journal-title":"Br. J. Exp. Pathol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1177\/10406387211015294","article-title":"Vaccination with Rift Valley fever virus live attenuated vaccine strain Smithburn caused meningoencephalitis in alpacas","volume":"33","author":"Anthony","year":"2021","journal-title":"J. Vet. Diagn. Investig."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/oxfordjournals.aje.a113471","article-title":"A rift Valley fever vaccine trial: I. Side effects and serologic response over a six-month follow-up","volume":"116","author":"Kark","year":"1982","journal-title":"Am. J. Epidemiol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0264-410X(85)90061-1","article-title":"Rift Valley fever virus vaccine trial: Study of neutralizing antibody response in humans","volume":"3","author":"Niklasson","year":"1985","journal-title":"Vaccine"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0264-410X(99)00218-2","article-title":"Immunogenicity of an inactivated Rift Valley fever vaccine in humans: A 12-year experience","volume":"18","author":"Pittman","year":"1999","journal-title":"Vaccine"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1016\/j.vaccine.2011.02.037","article-title":"Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study","volume":"29","author":"Rusnak","year":"2011","journal-title":"Vaccine"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41541-020-0166-9","article-title":"Rift Valley fever virus vaccination induces long-lived, antigen-specific human T cell responses","volume":"5","author":"Harmon","year":"2020","journal-title":"npj Vaccines"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1099\/0022-1317-66-10-2271","article-title":"Mutagen-directed Attenuation of Rift Valley Fever Virus as a Method for Vaccine Development","volume":"66","author":"Caplen","year":"1985","journal-title":"J. Gen. Virol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-1702(97)00097-X","article-title":"Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation","volume":"52","author":"Vialat","year":"1997","journal-title":"Virus Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0264-410X(91)90314-V","article-title":"Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep","volume":"9","author":"Morrill","year":"1991","journal-title":"Vaccine"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1128\/CVI.00114-15","article-title":"Evaluation of the Efficacy, Potential for Vector Transmission, and Duration of Immunity of MP-12, an Attenuated Rift Valley Fever Virus Vaccine Candidate, in Sheep","volume":"22","author":"Miller","year":"2015","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.vaccine.2016.12.003","article-title":"Vaccination of alpacas against Rift Valley fever virus: Safety, immunogenicity and pathogenicity of MP-12 vaccine","volume":"35","author":"Rissmann","year":"2017","journal-title":"Vaccine"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/infdis\/jir249","article-title":"Protection of MP-12-Vaccinated Rhesus Macaques Against Parenteral and Aerosol Challenge with Virulent Rift Valley Fever Virus","volume":"204","author":"Morrill","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/14760584.2017.1321482","article-title":"Rift Valley fever vaccines: An overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate","volume":"16","author":"Ikegami","year":"2017","journal-title":"Expert Rev. Vaccines"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.vetmic.2014.04.007","article-title":"Evaluation of lamb and calf responses to Rift Valley fever MP-12 vaccination","volume":"172","author":"Wilson","year":"2014","journal-title":"Vet. Microbiol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/infdis\/jir354","article-title":"Mucosal Immunization of Rhesus Macaques with Rift Valley Fever MP-12 Vaccine","volume":"204","author":"Morrill","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.vaccine.2015.12.030","article-title":"Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans","volume":"34","author":"Pittman","year":"2016","journal-title":"Vaccine"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.vaccine.2015.11.078","article-title":"Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates","volume":"34","author":"Pittman","year":"2016","journal-title":"Vaccine"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.1995.53.405","article-title":"Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment","volume":"53","author":"Muller","year":"1995","journal-title":"Am. Soc. Trop. Med. Hyg."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1016\/j.vaccine.2010.04.085","article-title":"Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep","volume":"28","author":"Dungu","year":"2010","journal-title":"Vaccine"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1016\/j.vaccine.2011.05.055","article-title":"Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves","volume":"29","author":"Engelbrecht","year":"2011","journal-title":"Vaccine"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"779858","DOI":"10.3389\/fvets.2021.779858","article-title":"Safety, Immunogenicity and Antibody Persistence of Rift Valley Fever Virus Clone 13 Vaccine in Sheep, Goats and Cattle in Tanzania","volume":"8","author":"Sindato","year":"2021","journal-title":"Front. Vet. Sci."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"857","DOI":"10.4102\/ojvr.v82i1.857","article-title":"Safety and immunogenicity of Onderstepoort Biological Products\u2019 Rift Valley fever Clone 13 vaccine in sheep and goats under field conditions in Senegal","volume":"82","author":"Lo","year":"2015","journal-title":"Onderstepoort J. Vet. Res."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Makoschey, B., van Kilsdonk, E., Hubers, W.R., Vrijenhoek, M.P., Smit, M., Schreur, P.J.W., Kortekaas, J., and Moulin, V. (2016). Rift Valley Fever Vaccine Virus Clone 13 Is Able to Cross the Ovine Placental Barrier Associated with Foetal Infections, Malformations, and Stillbirths. PLoS Negl. Trop. Dis., 10.","DOI":"10.1371\/journal.pntd.0004550"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"10883","DOI":"10.1128\/JVI.00961-14","article-title":"Creation of Rift Valley Fever Viruses with Four-Segmented Genomes Reveals Flexibility in Bunyavirus Genome Packaging","volume":"88","author":"Schreur","year":"2014","journal-title":"J. Virol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41541-022-00476-y","article-title":"Safety and immunogenicity of four-segmented Rift Valley fever virus in the common marmoset","volume":"7","author":"Schreur","year":"2022","journal-title":"npj Vaccines"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.vaccine.2015.01.077","article-title":"Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination","volume":"33","author":"Schreur","year":"2015","journal-title":"Vaccine"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1016\/j.vaccine.2017.04.024","article-title":"Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy","volume":"35","author":"Schreur","year":"2017","journal-title":"Vaccine"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41541-020-00212-4","article-title":"Safety and efficacy of four-segmented Rift Valley fever virus in young sheep, goats and cattle","volume":"5","author":"Schreur","year":"2020","journal-title":"NPJ Vaccines"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/j.vaccine.2013.12.064","article-title":"Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep","volume":"32","author":"Weingartl","year":"2014","journal-title":"Vaccine"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1128\/JVI.02501-07","article-title":"Rift Valley Fever Virus Lacking the NSs and NSm Genes Is Highly Attenuated, Confers Protective Immunity from Virulent Virus Challenge, and Allows for Differential Identification of Infected and Vaccinated Animals","volume":"82","author":"Bird","year":"2008","journal-title":"J. Virol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1016\/j.vaccine.2005.08.034","article-title":"Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus","volume":"24","author":"Spik","year":"2006","journal-title":"Vaccine"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Bhardwaj, N., Heise, M.T., and Ross, T.M. (2010). Vaccination with DNA Plasmids Expressing Gn Coupled to C3d or Alphavirus Replicons Expressing Gn Protects Mice against Rift Valley Fever Virus. PLoS Negl. Trop. Dis., 4.","DOI":"10.1371\/journal.pntd.0000725"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.virol.2007.04.014","article-title":"Comparative analysis of the alphavirus-based vectors expressing Rift Valley fever virus glycoproteins","volume":"366","author":"Gorchakov","year":"2007","journal-title":"Virology"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced Immunogenicity and Protective Efficacy Against Mycobacterium tuberculosis of Bacille Calmette-Gu\u00e9rin Vaccine Using Mucosal Administration and Boosting with a Recombinant Modified Vaccinia Virus Ankara","volume":"171","author":"Goonetilleke","year":"2003","journal-title":"J. Immunol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1348-0421.2002.tb02672.x","article-title":"Immunogenicity of a Recombinant MVA and a DNA Vaccine for Japanese Encephalitis Virus in Swine","volume":"46","author":"Nam","year":"2002","journal-title":"Microbiol. Immunol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0264-410X(02)00076-2","article-title":"Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA\/MVA vaccine","volume":"20","author":"Amara","year":"2002","journal-title":"Vaccine"},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Gil, E., Lorenzo, G., Hevia, E., Borrego, B., Eiden, M., Groschup, M., Gilbert, S.C., and Brun, A. (2013). A Single Immunization with MVA Expressing GnGc Glycoproteins Promotes Epitope-specific CD8+-T Cell Activation and Protects Immune-competent Mice against a Lethal RVFV Infection. PLoS Negl. Trop. Dis., 7.","DOI":"10.1371\/journal.pntd.0002309"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1016\/j.vaccine.2006.06.041","article-title":"Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever","volume":"24","author":"Wallace","year":"2006","journal-title":"Vaccine"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/1743-422X-10-349","article-title":"Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice","volume":"10","author":"Warimwe","year":"2013","journal-title":"Virol. J."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41541-019-0138-0","article-title":"Safety and efficacy of ChAdOx1 RVF vaccine against Rift Valley fever in pregnant sheep and goats","volume":"4","author":"Stedman","year":"2019","journal-title":"npj Vaccines"},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Zhang, S., Yan, F., Liu, D., Li, E., Feng, N., Xu, S., Wang, H., Gao, Y., Yang, S., and Zhao, Y. (2022). Bacterium-Like Particles Displaying the Rift Valley Fever Virus Gn Head Protein Induces Efficacious Immune Responses in Immunized Mice. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.799942"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jmv.20624","article-title":"Adverse response of non-indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine","volume":"78","author":"Botros","year":"2006","journal-title":"J. Med. Virol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1743-422X-6-94","article-title":"Pathological studies on postvaccinal reactions of Rift Valley fever in goats","volume":"6","author":"Kamal","year":"2009","journal-title":"Virol. J."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"e69630","DOI":"10.7554\/eLife.69630","article-title":"How will mosquitoes adapt to climate warming?","volume":"10","author":"Couper","year":"2021","journal-title":"eLife"},{"key":"ref_159","unstructured":"World Health Organization (2023, August 15). Prioritizing Diseases for Research and Development in Emergency Contexts. Available online: https:\/\/www.who.int\/activities\/prioritizing-diseases-for-research-and-development-in-emergency-contexts."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/tbed.14093","article-title":"Black rats (Rattus rattus) as potential reservoir hosts for Rift Valley fever phlebovirus: Experimental infection results in viral replication and shedding without clinical manifestation","volume":"69","author":"Stoek","year":"2021","journal-title":"Transbound. Emerg. Dis."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1089\/vbz.2021.0054","article-title":"Genetic Characterization of Rift Valley Fever Virus in Insectivorous Bats, Egypt","volume":"21","author":"Saeed","year":"2021","journal-title":"Vector-Borne Zoonotic Dis."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1128\/JVI.02095-06","article-title":"Complete Genome Analysis of 33 Ecologically and Biologically Diverse Rift Valley Fever Virus Strains Reveals Widespread Virus Movement and Low Genetic Diversity due to Recent Common Ancestry","volume":"81","author":"Bird","year":"2007","journal-title":"J. Virol."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Cartwright, H.N., Barbeau, D.J., and McElroy, A.K. (2020). Rift Valley Fever Virus Is Lethal in Different Inbred Mouse Strains Independent of Sex. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.01962"}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/12\/9\/1174\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:53:33Z","timestamp":1760129613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/12\/9\/1174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,19]]},"references-count":163,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["pathogens12091174"],"URL":"https:\/\/doi.org\/10.3390\/pathogens12091174","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,19]]}}}